NMAD on Nasdaq

NOMAD POWER SOLUTIONS, INC.

American pharmaceutical preparations company based in Pasadena.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Clene Inc., BIOXYTRAN, INC or Anixa Biosciences Inc, or pick any stock.

TickerNMAD on Nasdaq
IndustryPharmaceutical Preparations
HeadquartersPasadena, United States
Incorporated inDE²
Business address433 Plaza Real, Suite 275, Boca Raton, Fl 33432²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income³⁴⁵⁶⁷⁸-$5.1M in 2025+105% since 2019

Net income³⁴⁵⁶⁷⁸-$6.1M in 2025+149% since 2019

Every line of the income statement as filed: the last 2 fiscal years, latest first.⁸

Period ending	2025-12-31	2024-12-31
General and administrative costs (includes $1,388,322 and $418,422 of stock-based compensation, respectively)	$4.9M	$2.8M
Research and development costs	$254.9K	$726.2K
Total costs and expenses	$5.1M	$3.6M
Loss from operations	-$5.1M	-$3.6M
Interest Income	$7.4K	$7.0K
Interest Expense	-$9.2K	-$16.8K
Realized loss on digital assets	-$904.4K
Foreign currency gain (loss)	$525	-$3.4K
Other income	$3.7K
Net loss	-$6.0M	-$3.6M
Series B Convertible Preferred Stock 8% cumulative dividend	-$69.1K
Net loss attributable to common stockholders	-$6.1M	-$3.6M
Earnings Per Share, Diluted	-$1.26	-$1.59
Weighted Average Number of Shares Outstanding, Diluted	4.8M shares	2.2M shares
Share based compensation	$1.4M	$418.4K

Total assets³⁴⁵⁶⁷⁸$12.7M in 2025+377% since 2019

Total liabilities⁸$1.8M in 2025+457% since 2024

Shareholders’ equity⁴⁵⁶⁷⁸$9.7M in 2025+297% since 2019

Cash³⁴⁵⁶$4.2M in 2023+62% since 2019

Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.⁸

Period ending	2025-12-31	2025-11-30	2024-12-31	2023-12-31
Cash	$5.1M		$1.0M
Prepaid insurance	$26.7K		$20.9K
Other prepaid expenses	$44.8K		$85.7K
Total current assets	$5.2M		$1.1M
LiGHT proton therapy system equipment	$6.6M
Right-of-use lease assets	$972.7K	$1.0M
Total assets	$12.7M		$1.1M
Research and development contract liabilities	$232.1K		$235.1K
Operating lease obligations, current	$595.4K
Series B Convertible Preferred Stock 8% cumulative dividend payable	$69.1K
Total current liabilities	$1.3M		$318.3K
Operating lease obligations, long-term	$439.0K
Total liabilities	$1.8M		$318.3K
Common stock, $0.0001 par value authorized 100,000,000 shares; issued and outstanding 8,790,102 and 2,249,290 shares at December 31, 2025 and 2024, respectively	$879		$225
Additional paid-in capital	$66.0M		$49.4M
Accumulated deficit	-$58.1M		-$52.1M
Total Lixte Biotechnology stockholders equity	$9.7M		$827.2K
Non-controlling interest	$1.3M
Total stockholders equity	$11.0M		$827.2K	$4.0M
Total liabilities and stockholders equity	$12.7M		$1.1M
Related parties accounts payable and accrued expenses	$436.5K		$83.2K
Preferred stock, par value	$0.00		$0.00
Preferred stock, shares authorized	10.0M shares		10.0M shares
Common stock, par value	$0.00		$0.00
Common stock, shares authorized	100.0M shares		100.0M shares
Common stock, shares issued	8.8M shares		2.2M shares
Common stock, shares outstanding	8.8M shares		2.2M shares

Period ending	2025-12-31	2025-11-30	2024-12-31	2023-12-31
Cash	$5.1M		$1.0M
Prepaid insurance	$26.7K		$20.9K
Other prepaid expenses	$44.8K		$85.7K
Total current assets	$5.2M		$1.1M
LiGHT proton therapy system equipment	$6.6M
Right-of-use lease assets	$972.7K	$1.0M
Total assets	$12.7M		$1.1M
Research and development contract liabilities	$232.1K		$235.1K
Operating lease obligations, current	$595.4K
Series B Convertible Preferred Stock 8% cumulative dividend payable	$69.1K
Total current liabilities	$1.3M		$318.3K
Operating lease obligations, long-term	$439.0K
Total liabilities	$1.8M		$318.3K
Common stock, $0.0001 par value authorized 100,000,000 shares; issued and outstanding 8,790,102 and 2,249,290 shares at December 31, 2025 and 2024, respectively	$879		$225
Additional paid-in capital	$66.0M		$49.4M
Accumulated deficit	-$58.1M		-$52.1M
Total Lixte Biotechnology stockholders equity	$9.7M		$827.2K
Non-controlling interest	$1.3M
Total stockholders equity	$11.0M		$827.2K	$4.0M
Total liabilities and stockholders equity	$12.7M		$1.1M
Related parties accounts payable and accrued expenses	$436.5K		$83.2K
Preferred stock, par value	$0.00		$0.00
Preferred stock, shares authorized	10.0M shares		10.0M shares
Common stock, par value	$0.00		$0.00
Common stock, shares authorized	100.0M shares		100.0M shares
Common stock, shares issued	8.8M shares		2.2M shares
Common stock, shares outstanding	8.8M shares		2.2M shares

Cash from operations³⁴⁵⁶⁷⁸-$3.1M in 2025

Every line of the cash flow as filed: the last 2 fiscal years, latest first.⁸

Period ending	2025-12-31	2024-12-31
Net loss	-$6.0M	-$3.6M
Non-cash lease expense for right-of-use asset	$61.7K
Stock-based compensation expense	$1.4M	$418.4K
Common stock issued for services	$171.6K
Realized loss on digital assets	$904.4K
Advances on research and development contract services		$78.0K
Prepaid insurance	-$5.8K	-$3.8K
Other prepaid expenses	$40.8K	-$75.7K
Accounts payable and accrued expenses	$380.8K	-$73.6K
Research and development contract liabilities	-$2.9K	$78.0K
Net cash used in operating activities	-$3.1M	-$3.2M
Purchase of digital assets	-$2.6M
Cash paid for Liora investment	-$440.0K
Capitalized transaction costs	-$95.1K
Net cash used in investing activities	-$3.2M
Proceeds from sale of securities in registered direct offerings, net of offering costs	$6.1M
Proceeds from sale of securities in registered private placement, net of offering costs	$4.2M
Exercise of common stock warrants	$45.8K
Net cash provided by financing activities	$10.3M
NET CHANGE IN CASH	$4.1M	-$3.2M
Cash paid for interest	$9.2K	$16.8K
Options issued to settle accrued Board fees	$27.5K
Exercise of placement agent warrants on a cashless basis	$22
Exercise of pre-funded warrants	$306
Conversion of Series A Convertible Preferred Stock into common stock	$3.5M
Conversion of Series B Convertible Preferred Stock into common stock	$821.8K
Accrual of Series B Convertible Preferred Stock 8% cumulative dividend	$69.1K
Dividend payable settled in shares	$20.1K
Digital assets transferred as consideration for acquisition of Liora (non-cash investing) FV at transfer	$1.7M
Common stock issued for acquisition of Liora	$3.0M
Right-of use asset and lease liability - operating lease (UKRI Daresbury)	$1.0M
Non-controlling interest	$1.3M
Accrual of deferred offering costs		$6.9K

Compare NOMAD POWER SOLUTIONS, INC. with another company

Leadership

Who has led NOMAD POWER SOLUTIONS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

Chair

Geordan Garrett Pursglove2025–now

President

Chief financial officer

Chief operating officer

Eric Forman2022

2010201520202025

Chief executive officerGeordan Garrett Pursglove Jun 18, 2025 to now¹¹
Chief executive officerDer Baan Bastiaan Jeroen Van Sep 27, 2023 to Oct 16, 2023¹²
Chief executive officerJohn S. Kovach Dec 2, 2020 to Nov 9, 2022¹³
ChairGeordan Garrett Pursglove Jun 18, 2025 to now¹¹
PresidentDer Baan Bastiaan Jeroen Van Sep 27, 2023 to Oct 16, 2023¹²
PresidentJohn S. Kovach Mar 19, 2015 to Nov 9, 2022¹⁴
Chief financial officerPeter Stazzone Sep 4, 2025 to now¹⁵
Chief financial officerRobert N. Weingarten Aug 20, 2020 to Nov 9, 2022¹⁶
Chief financial officerJohn S. Kovach Jul 21, 2006 to Jul 21, 2006¹⁷
Chief operating officerEric Forman Nov 9, 2022 to Dec 13, 2022¹⁸

Board members and other officers (18)

Chief Medical OfficerJohannes Henricus Matthias Schellens Aug 1, 2024 to Aug 1, 2024¹⁹
Vice chairDer Baan Bastiaan Jeroen Van Oct 16, 2023 to Oct 16, 2023²⁰
Chief Medical OfficerJames Miser Nov 21, 2022 to Nov 21, 2022²¹
SecretaryEric Forman Jan 4, 2021 to Apr 6, 2022²²
Board memberStuart D. Porter Jun 1, 2026 to now²³
Board memberJohn Francis Travaglini Jul 2, 2026 to now²⁴
Board memberJason David Sawyer Jul 21, 2025 to now²⁵
Board memberMichael Andrew Holloway Jul 21, 2025 to now²⁶
Board memberLourdes Felix Sep 4, 2025 to now²⁷
Board memberGuy Warren Primus Sep 10, 2025 to now²⁸
Board memberDer Baan Bastiaan Jeroen Van Jul 18, 2022 to Oct 16, 2023²⁹
Board memberRene Bernards Jul 28, 2022 to now³⁰
Board memberSze Chun Winson Ho Aug 14, 2018 to Jan 14, 2021³¹
Board memberYun Yen Aug 14, 2018 to now³²
Board memberStephen J. Forman Jun 7, 2016 to now³³
Board memberRobert B. Royds May 10, 2011 to May 10, 2011³⁴
Board memberMel Sorensen Oct 8, 2008 to Oct 8, 2008³⁵
Board memberJohn S. Kovach Jul 21, 2006 to Nov 9, 2022¹⁷

Former names

LIXTE BIOTECHNOLOGY HOLDINGS, INC.Oct 4, 2006 to Jul 2, 2026²
SRKP 7 INCAug 3, 2005 to Dec 1, 2006²

Timeline

Jun 18, 2025New chief executive Geordan Garrett Pursglove becomes CEO¹¹
Sep 27, 2023New chief executive Der Baan Bastiaan Jeroen Van becomes CEO¹²
Dec 2, 2020New chief executive John S. Kovach becomes CEO¹³
May 24, 2005Founded NOMAD POWER SOLUTIONS, INC. is founded³⁶

Filings

260 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 90 major events, 81 insider forms, 8 large holders, 1 private raises, 60 other. The latest 20:

Oct 6, 20268-K EDGAR
Sep 30, 20268-K EDGAR
Sep 17, 20268-K/A EDGAR
Aug 14, 202610-Q EDGAR
Jul 31, 2026SCHEDULE 13G EDGAR
Jul 31, 20268-K EDGAR
Jul 27, 2026DEF 14A EDGAR
Jul 17, 2026PRE 14A EDGAR
Jul 10, 20268-K EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20268-K EDGAR
Jul 2, 20263 EDGAR
Jun 18, 20268-K EDGAR
Jun 16, 20268-K EDGAR
Jun 9, 2026SCHEDULE 13G EDGAR

The 260 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 8 such filings since October 2021:

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

Jul 20, 2023Raised $3.5 million in a private offering of securities Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Legacy Wealth Managment, LLC/ID	600,669	$4.5M	1.8%	New
Vanguard Capital Management LLC	555,476	$4.1M	0.0%	+505,997
Scotia Capital Inc.	283,162	$2.1M	0.0%	No change
Geode Capital Management, LLC	143,036	$1.1M	0.0%	+84,184
BlackRock, Inc.	75,958	$563.6K	0.0%	New
State Street Corp	75,096	$557.2K	0.0%	+57,700
Vanguard Fiduciary Trust Co	67,280	$499.2K	0.0%	+32,246
Federation des caisses Desjardins du Quebec	38,130	$282.9K	0.0%	−26,357
Northern Trust Corp	27,655	$205.2K	0.0%	New
Axxcess Wealth Management, LLC	13,771	$102.2K	0.0%	New
Atlas Legacy Advisors, LLC	13,771	$102.2K	0.0%	No change
Ethos Financial Group, LLC	24,808	$99.7K	0.0%	No change
Equitable Holdings, Inc.	10,000	$74.2K	0.0%	New
UBS Group AG	6,400	$47.5K	0.0%	New
Integrated Wealth Concepts LLC	246	$1.8K	0.0%	New
SBI Securities Co., Ltd.	190	$1.4K	0.0%	No change
Caitong International Asset Management Co., Ltd	7	$52	0.0%	New
Wells Fargo & Company/mn	5	$37	0.0%	New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNOMAD POWER SOLUTIONS, INC. filings on SEC EDGAR
2
SEC EDGARNOMAD POWER SOLUTIONS, INC. filings on SEC EDGAR
3
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2019
4
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2020
5
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2021
6
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2022
7
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2023
8
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-K for fiscal 2024
9
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-Q for fiscal 2026
10
SEC EDGARNOMAD POWER SOLUTIONS, INC. 10-Q for fiscal 2026
11
SEC EDGARGeordan Garrett Pursglove, Chief executive officer
12
SEC EDGARDer Baan Bastiaan Jeroen Van, Chief executive officer
13
SEC EDGARJohn S. Kovach, Chief executive officer
14
SEC EDGARJohn S. Kovach, President
15
SEC EDGARPeter Stazzone, Chief financial officer
16
SEC EDGARRobert N. Weingarten, Chief financial officer
17
SEC EDGARJohn S. Kovach, Chief financial officer
18
SEC EDGAREric Forman, Chief operating officer
19
SEC EDGARJohannes Henricus Matthias Schellens, Chief Medical Officer
20
SEC EDGARDer Baan Bastiaan Jeroen Van, Vice chair
21
SEC EDGARJames Miser, Chief Medical Officer
22
SEC EDGAREric Forman, Secretary
23
SEC EDGARStuart D. Porter, Board member
24
SEC EDGARJohn Francis Travaglini, Board member
25
SEC EDGARJason David Sawyer, Board member
26
SEC EDGARMichael Andrew Holloway, Board member
27
SEC EDGARLourdes Felix, Board member
28
SEC EDGARGuy Warren Primus, Board member
29
SEC EDGARDer Baan Bastiaan Jeroen Van, Board member
30
SEC EDGARRene Bernards, Board member
31
SEC EDGARSze Chun Winson Ho, Board member
32
SEC EDGARYun Yen, Board member
33
SEC EDGARStephen J. Forman, Board member
34
SEC EDGARRobert B. Royds, Board member
35
SEC EDGARMel Sorensen, Board member
36
gleifNOMAD POWER SOLUTIONS, INC. is founded